Loading publications…
The last 5 uploaded publications
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
Jane Goodall, Joaquı́n Mateo, Wei Yuan, Helen Mossop, Núria Porta, Susana Miranda, Raquel Pérez-López, David Dolling, Dan R. Robinson, Shahneen Sandhu, Gemma Fowler, Berni Ebbs, Penny Flohr, George Seed, Daniel Nava Rodrigues, Gunther Boysen, Cláudia Bertan, Mark Atkin, Matthew Clarke, Mateus Crespo, Ines Figueiredo, Ruth Riisnaes, Semini Sumanasuriya, Pasquale Rescigno, Zafeiris Zafeiriou, Adam Sharp, Nina Tunariu, Diletta Bianchini, Alexa Gillman, Christopher J. Lord, Emma Hall, Arul M. Chinnaiyan, Suzanne Carreira, Johann S. de Bono (2017). Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. , 7(9), DOI: https://doi.org/10.1158/2159-8290.cd-17-0261.
Article61 days agoDNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Pérez-López, Daniel Nava Rodrigues, Dan R. Robinson, Aurelius Omlin, Nina Tunariu, Gunther Boysen, Núria Porta, Penny Flohr, Alexa Gillman, Ines Figueiredo, Claire Paulding, George Seed, Suneil Jain, Christy Ralph, Andrew Protheroe, Syed A. Hussain, Robert J. Jones, Tony Elliott, Ursula McGovern, Diletta Bianchini, Jane Goodall, Zafeiris Zafeiriou, Chris T. Williamson, Roberta Ferraldeschi, Ruth Riisnaes, Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono (2015). DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. , 373(18), DOI: https://doi.org/10.1056/nejmoa1506859.
Article61 days agoAbstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer
Joaquı́n Mateo, Shahneen Sandhu, Susana Miranda, Suzanne Carreira, Suneil Jain, Christy Ralph, Andrew Protheroe, Syed A. Hussain, Robert J. Jones, Tony Elliot, Ursula McGovern, Alexa Gillman, Claire Paulding, Helen Mossop, Núria Porta, Diletta Bianchini, Zafeiris Zafeiriou, Gunther Boysen, Daniel Nava Rodrigues, Penelope Flohr, George Seed, Jane Goodall, Ines Figueiredo, Raquel Pérez-López, Nina Tunariu, Aurelius Omlin, Roberta Ferraldeschi, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Dan R. Robinson, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono (2015). Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer. , 75(15_Supplement), DOI: https://doi.org/10.1158/1538-7445.am2015-ct322.
Article61 days agoAntitumour Activity of the Parp Inhibitor Olaparib in Unselected Sporadic Castration-Resistant Prostate Cancer (Crpc) in the Toparp Trial
Jane Goodall, Alexa Gillman, Helen Mossop, Christy Ralph, Zafeiris Zafeiriou, Raquel Pérez López, Nina Tunariu, Roberta Ferraldeschi, Daniel Nava Rodrigues, Lakshmi P. Kunju, Dan R. Robinson, Gerhardt Attard, Arul M. Chinnaiyan, Johann S. de Bono, Joaquı́n Mateo, Emma Hall, Shahneen Sandhu, Aurelius Omlin, Susana Miranda, Suzanne Carreira (2014). Antitumour Activity of the Parp Inhibitor Olaparib in Unselected Sporadic Castration-Resistant Prostate Cancer (Crpc) in the Toparp Trial. , 25, DOI: https://doi.org/10.1093/annonc/mdu438.20.
Article61 days ago